E-LIB Suche - Ergebnisse für: Hanson, Lyndsey

1

AZD4625 is a Potent and Selective Inhibitor of KRASG12C:

Chakraborty, Atanu ; Hanson, Lyndsey ; Robinson, David...
Molecular Cancer Therapeutics. 21 (2022) 10 - p. 1535-1546 , 2022

Link: https://doi.org/10.1158/..

2

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C In..:

Khawaja, Hajrah ; Briggs, Rebecca ; Latimer, Cheryl H....
Molecular Cancer Therapeutics. 22 (2022) 1 - p. 135-149 , 2022

Link: https://doi.org/10.1158/..

3

Discovery of AZD4625, a Covalent Allosteric Inhibitor of th..:

Kettle, Jason G. ; Bagal, Sharan K. ; Bickerton, Sue...
Journal of Medicinal Chemistry. 65 (2022) 9 - p. 6940-6952 , 2022

Link: https://doi.org/10.1021/..

4

Antisense oligonucleotide activity in tumour cells is influ..:

Kapustin, Alexander N. ; Davey, Paul ; Longmire, David...
Communications Biology. 4 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

5

Structure-Based Design and Pharmacokinetic Optimization of ..:

Kettle, Jason G. ; Bagal, Sharan K. ; Bickerton, Sue...
Journal of Medicinal Chemistry. 63 (2020) 9 - p. 4468-4483 , 2020

Link: https://doi.org/10.1021/..

6

Discovery of a Potent and Selective Oral Inhibitor of ERK1/..:

Ward, Richard A. ; Anderton, Mark J. ; Bethel, Paul...
Journal of Medicinal Chemistry. 62 (2019) 24 - p. 11004-11018 , 2019

Link: https://doi.org/10.1021/..

7

Structure-Guided Discovery of Potent and Selective Inhibito..:

Ward, Richard A. ; Bethel, Paul ; Cook, Calum...
Journal of Medicinal Chemistry. 60 (2017) 8 - p. 3438-3450 , 2017

Link: https://doi.org/10.1021/..

8

Discovery of a novel aminopyrazine series as selective PI3K..:

Barlaam, Bernard ; Cosulich, Sabina ; Fitzek, Martina...
Bioorganic & Medicinal Chemistry Letters. 27 (2017) 13 - p. 3030-3035 , 2017

Link: https://doi.org/10.1016/..

9

Bcl-xL Is a Key Mediator of Apoptosis Following KRAS(G12C) ..:

Khawaja, Hajrah ; Briggs, Rebecca ; Latimer, Cheryl H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808374/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C In..:

Khawaja, Hajrah ; Briggs, Rebecca ; Latimer, Cheryl H...
info:eu-repo/semantics/altIdentifier/pmid/36279564. , 2023

Link: https://hdl.handle.net/2..

11

Bcl-xL is a key mediator of apoptosis following KRAS G12C i..:

Khawaja, Hajrah ; Briggs, Rebecca ; Latimer, Cheryl H...
Khawaja , H , Briggs , R , Latimer , C H , Rassel , M , Griffin , D , Hanson , L , Bardelli , A , Di Nicolantonio , F , McDade , S S , Scott , C J , Lambe , S , Maurya , M , Lindner , A U , Prehn , J H M , Sousa , J , Winnington , C , LaBonte , M J , Ross , S & Van Schaeybroeck , S 2023 , ' Bcl-xL is a key mediator of apoptosis following KRAS G12C inhibition in KRAS G12C -mutant colorectal cancer ' , Molecular Cancer Therapeutics , vol. 22 , no. 1 , pp. 135–149 . https://doi.org/10.1158/1535-7163.mct-22-0301. , 2023

Link: https://pure.qub.ac.uk/e..

12

AZD4625 is a Potent and Selective Inhibitor of KRAS(G12C):

Chakraborty, Atanu ; Hanson, Lyndsey ; Robinson, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538594/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Antisense oligonucleotide activity in tumour cells is influ..:

Kapustin, Alexander N ; Davey, Paul ; Longmire, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560811/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Specific targeting of the KRAS mutational landscape in myel..:

Sacco, Antonio ; Federico, Cinzia ; Todoerti, Katia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710471/. , 2021

Link: http://www.ncbi.nlm.nih...

15

1451 The implantation site impacts the tumour growth kineti..:

Emily Wright ; Stewart Brown ; Lorraine Mooney...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..